Viewing Study NCT05345327


Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2025-12-26 @ 4:17 AM
Study NCT ID: NCT05345327
Status: RECRUITING
Last Update Posted: 2024-12-20
First Post: 2022-04-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Sponsor: The George Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module